1. Etminan M, Sodhi M, Ganjizadeh-Zavareh S, Carleton B, Kezouh A, Brophy JM. 2019; Oral fluoroquinolones and risk of mitral and aortic regurgitation. J Am Coll Cardiol. 74:1444–50. DOI:
10.1016/j.jacc.2019.07.035. PMID:
31514945.
2. Michalak K, Sobolewska-Włodarczyk A, Włodarczyk M, Sobolewska J, Woźniak P, Sobolewski B. 2017; Treatment of the fluoroquinolone-associated disability: the pathobiochemical implications. Oxid Med Cell Longev. 2017:8023935. DOI:
10.1155/2017/8023935. PMID:
29147464. PMCID:
PMC5632915.
Article
3. Singh S, Nautiyal A. 2017; Aortic dissection and aortic aneurysms associated with fluoroquinolones: a systematic review and meta-analysis. Am J Med. 130:1449–57.e9. DOI:
10.1016/j.amjmed.2017.06.029. PMID:
28739200.
Article
4. Jackson MA, Schutze GE. Committee on Infectious Diseases. 2016; The use of systemic and topical fluoroquinolones. Pediatrics. 138:e20162706. DOI:
10.1542/peds.2016-2706. PMID:
27940800.
Article
7. Lee CC, Lee MT, Chen YS, Lee SH, Chen YS, Chen SC, Chang SC. 2015; Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone. JAMA Intern Med. 175:1839–47. DOI:
10.1001/jamainternmed.2015.5389. PMID:
26436523.
Article
9. Pasternak B, Inghammar M, Svanström H. 2018; Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study. BMJ. 360:k678. DOI:
10.1136/bmj.k678. PMID:
29519881. PMCID:
PMC5842359.
Article
10. Clouse WD, Hallett JW Jr, Schaff HV, Spittell PC, Rowland CM, Ilstrup DM, Melton LJ 3rd. 2004; Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc. 79:176–80. DOI:
10.4065/79.2.176. PMID:
14959911.
Article
12. Goldfinger JZ, Halperin JL, Marin ML, Stewart AS, Eagle KA, Fuster V. 2014; Thoracic aortic aneurysm and dissection. J Am Coll Cardiol. 64:1725–39. DOI:
10.1016/j.jacc.2014.08.025. PMID:
25323262.
Article
13. Corps AN, Harrall RL, Curry VA, Fenwick SA, Hazleman BL, Riley GP. 2002; Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum. 46:3034–40. DOI:
10.1002/art.10617. PMID:
12428247.
14. Tsai WC, Hsu CC, Chen CP, Chang HN, Wong AM, Lin MS, Pang JH. 2011; Ciprofloxacin up-regulates tendon cells to express matrix metalloproteinase-2 with degradation of type I collagen. J Orthop Res. 29:67–73. DOI:
10.1002/jor.21196. PMID:
20602464.
Article
15. Chang HN, Pang JH, Chen CP, Ko PC, Lin MS, Tsai WC, Yang YM. 2012; The effect of aging on migration, proliferation, and collagen expression of tenocytes in response to ciprofloxacin. J Orthop Res. 30:764–8. DOI:
10.1002/jor.21576. PMID:
22021103.
Article
16. Paget GE, Barnes JM. Laurenc DR, Bacharach AL, editors. 1964. Chapter 6- toxicity tests. Evaluation of Drug Activities. Academic Press;New York: p. 135–66. DOI:
10.1016/B978-1-4832-2845-7.50012-8.
17. LeMaire SA, Zhang L, Luo W, Ren P, Azares AR, Wang Y, Zhang C, Coselli JS, Shen YH. 2018; Effect of ciprofloxacin on susceptibility to aortic dissection and rupture in mice. JAMA Surg. 153:e181804. DOI:
10.1001/jamasurg.2018.1804. PMID:
30046809. PMCID:
PMC6233654.
Article
18. Bancroft JD, Gamble M. 2008. Theory and practice of histological techniques. 6th ed. Churchill Livingstone/Elsevier;Philadelphia: p. 440.
20. Lee CC, Lee MG, Hsieh R, Porta L, Lee WC, Lee SH, Chang SS. 2018; Oral fluoroquinolone and the risk of aortic dissection. J Am Coll Cardiol. 72:1369–78. DOI:
10.1016/j.jacc.2018.06.067. PMID:
30213330.
21. Wang SW, Huang YB, Huang JW, Chiu CC, Lai WT, Chen CY. 2015; Epidemiology, clinical features, and prescribing patterns of aortic aneurysm in Asian population from 2005 to 2011. Medicine (Baltimore). 94:e1716. DOI:
10.1097/MD.0000000000001716. PMID:
26469911. PMCID:
PMC4616784.
Article
22. Howard DP, Banerjee A, Fairhead JF, Handa A, Silver LE, Rothwell PM. 2015; Population-based study of incidence of acute abdominal aortic aneurysms with projected impact of screening strategy. J Am Heart Assoc. 4:e001926. DOI:
10.1161/JAHA.115.001926. PMID:
26289347. PMCID:
PMC4599457.
Article
23. Abu-Dief EE, Abdelrahim EA, Abdelrahim KM. 2016; Histological modifications aging aorta in male albino rat. J Cytol Histol. 7:408. DOI:
10.4172/2157-7099.1000408.
Article
24. Zarkovic K, Larroque-Cardoso P, Pucelle M, Salvayre R, Waeg G, Nègre-Salvayre A, Zarkovic N. 2015; Elastin aging and lipid oxidation products in human aorta. Redox Biol. 4:109–17. DOI:
10.1016/j.redox.2014.12.008. PMID:
25553420. PMCID:
PMC4309857.
Article
25. Komutrattananont P, Palee P, Prasitwattanaseree S, Mahakkanukrauh P. 2020; The estimation of age from elastic fibers in the tunica media of the aortic wall in a thai population: a preliminary study using aorta image analysis. Anat Cell Biol. 53:284–91. DOI:
10.5115/acb.20.094. PMID:
32727957. PMCID:
PMC7527121.
Article
26. Fritze O, Romero B, Schleicher M, Jacob MP, Oh DY, Starcher B, Schenke-Layland K, Bujan J, Stock UA. 2012; Age-related changes in the elastic tissue of the human aorta. J Vasc Res. 49:77–86. DOI:
10.1159/000331278. PMID:
22105095.
Article
27. Greenberg SR. 1986; The association of medial collagenous tissue with atheroma formation in the aging human aorta as revealed by a special technique. Histol Histopathol. 1:323–6.
29. Wilson SK, Hutchins GM. 1982; Aortic dissecting aneurysms: causative factors in 204 subjects. Arch Pathol Lab Med. 106:175–80.
32. Ishii T, Asuwa N. 2000; Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. Hum Pathol. 31:640–6. DOI:
10.1053/hupa.2000.7642. PMID:
10872655.
Article
33. Macura KJ, Corl FM, Fishman EK, Bluemke DA. 2003; Pathogenesis in acute aortic syndromes: aortic dissection, intramural hematoma, and penetrating atherosclerotic aortic ulcer. AJR Am J Roentgenol. 181:309–16. DOI:
10.2214/ajr.181.2.1810309. PMID:
12876003.
Article
35. Sandison ME, Dempster J, McCarron JG. 2016; The transition of smooth muscle cells from a contractile to a migratory, phagocytic phenotype: direct demonstration of phenotypic modulation. J Physiol. 594:6189–209. DOI:
10.1113/JP272729. PMID:
27393389. PMCID:
PMC5088226.
Article
36. Atkinson J. 1998; Aging of arterial extracellular matrix elastin: etiology and consequences. Pathol Biol (Paris). 46:555–9. French.
37. James S, Schuijers J, Daffy J, Cook J, Samiric T. 2021; Ciprofloxacin reduces tenocyte viability and proteoglycan synthesis in short-term explant cultures of equine tendon. PeerJ. 9:e12003. DOI:
10.7717/peerj.12003. PMID:
34540363. PMCID:
PMC8411937.
Article